Instil Bio TIL Stock
10.9 USD
{{ price }}
-2.983073%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
70.86M USD
LOW - HIGH [24H]
10.57
-
10.96 USD
VOLUME [24H]
15.22K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-24 USD
Instil Bio Price Chart
Instil Bio TIL Financial and Trading Overview
| Instil Bio stock price | 10.9 USD |
| Previous Close | 0.56 USD |
| Open | 0.56 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 0.52 - 0.58 USD |
| 52 Week Range | 0.47 - 7.71 USD |
| Volume | 760.52K USD |
| Avg. Volume | 598.6K USD |
| Market Cap | 71.31M USD |
| Beta (5Y Monthly) | 1.282928 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -24 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5 USD |
TIL Valuation Measures
| Enterprise Value | -67195824 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.78314286 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.2291806 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.376 |
Trading Information
Instil Bio Stock Price History
| Beta (5Y Monthly) | 1.282928 |
| 52-Week Change | -88.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.71 USD |
| 52 Week Low | 0.47 USD |
| 50-Day Moving Average | 0.62 USD |
| 200-Day Moving Average | 1.78 USD |
TIL Share Statistics
| Avg. Volume (3 month) | 598.6K USD |
| Avg. Daily Volume (10-Days) | 583.25K USD |
| Shares Outstanding | 130.08M |
| Float | 68.09M |
| Short Ratio | 5.41 |
| % Held by Insiders | 6.84% |
| % Held by Institutions | 79.34% |
| Shares Short | 3.1M |
| Short % of Float | 4.95% |
| Short % of Shares Outstanding | 2.38% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.39% |
| Return on Equity (ttm) | -55.17% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -178802000 USD |
| Net Income Avi to Common (ttm) | -226128000 USD |
| Diluted EPS (ttm) | -1.7 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 223.2M USD |
| Total Cash Per Share (mrq) | 1.72 USD |
| Total Debt (mrq) | 83.35M USD |
| Total Debt/Equity (mrq) | 26.79 USD |
| Current Ratio (mrq) | 8.997 |
| Book Value Per Share (mrq) | 2.392 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -159775008 USD |
| Levered Free Cash Flow (ttm) | -172114624 USD |
Profile of Instil Bio
| Country | United States |
| State | TX |
| City | Dallas |
| Address | 3963 Maple Avenue |
| ZIP | 75219 |
| Phone | 972 499 3350 |
| Website | https://instilbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 192 |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
Q&A For Instil Bio Stock
What is a current TIL stock price?
Instil Bio TIL stock price today per share is 10.9 USD.
How to purchase Instil Bio stock?
You can buy TIL shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Instil Bio?
The stock symbol or ticker of Instil Bio is TIL.
Which industry does the Instil Bio company belong to?
The Instil Bio industry is Biotechnology.
How many shares does Instil Bio have in circulation?
The max supply of Instil Bio shares is 6.5M.
What is Instil Bio Price to Earnings Ratio (PE Ratio)?
Instil Bio PE Ratio is now.
What was Instil Bio earnings per share over the trailing 12 months (TTM)?
Instil Bio EPS is -24 USD over the trailing 12 months.
Which sector does the Instil Bio company belong to?
The Instil Bio sector is Healthcare.
Instil Bio TIL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}